Enterprise Value
52.87M
Cash
56.39M
Avg Qtr Burn
-17.4M
Short % of Float
9.29%
Insider Ownership
3.42%
Institutional Own.
45.32%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ATRC-101 (monoclonal antibody) Details Solid tumor/s | Phase 1b Data readout |